Literature DB >> 27987400

An insertion/deletion polymorphism within 3'UTR of RYR2 modulates sudden unexplained death risk in Chinese populations.

Shouyu Wang1, Zhixiang Zhang1, Ya Yang1, Chaoqun Wang1, Ruiyang Tao1, Shuxiang Hu1, Zhixia Yin1, Qing Zhang1, Lijuan Li1, Yan He2, Shaohua Zhu1, Chengtao Li3, Suhua Zhang3, Jianhua Zhang3, Lihui Sheng4, Fangyu Wu5, Bin Luo6, Yuzhen Gao7.   

Abstract

Sudden unexplained death (SUD) constitutes a part of the overall sudden death that can not be underestimated. Over the last years, genetic testing on SUD has revealed that inherited channelopathies might play important roles in the pathophysiology of this disease. Ryanodine receptor type-2 (RYR2) is a kind of ion channel extensively distributed in the sarcoplasmic reticulum (SR) of myocardium. Studies on RYR2 have suggested that either dysfunction or abnormal expression of it could lead to arrhythmia, which may cause cardiac arrest. In this study, we conducted a case-control study to evaluate the association of a 4-base pair (4-bp) Indel polymorphism (rs10692285) in the 3'UTR of RYR2 with the risk of SUD and sudden cardiac death induced by coronary heart disease (SCD-AS) in a Chinese population. Logistic regression analysis showed that the insertion allele of rs10692285 had significantly increased the risk of SUD [OR=2.03; 95% confidence interval (CI)=1.08-3.77; P=0.0161; statistical power=0.743]. No relevance was observed between rs10692285 and SCD-AS. Further genotype-phenotype association analysis suggested that the expression level of RYR2 in human myocardium tissues with the insertion allele was higher than that with the deletion allele at both mRNA and protein levels. Dual-Luciferase activity assay system was used to detect the effect of rs10692285 on the transcription activity of RYR2. As expected, the result indicated that the transcription activity of RYR2 with the ins/ins genotype was higher than that with the del/del genotype. Finally, in-silico prediction revealed that different alleles of rs10692285 could alter the local structure of RYR2 mRNA and microRNA (miRNA) binding. In summary, our findings provided evidence that rs10692285 might contribute to SUD susceptibility through affecting the expression of RYR2, which suggest that abnormal ion channel activity is very likely to be the underlying mechanism of SUD, but not for SCD-AS. Thus, rs10692285 may become a potential marker for molecular diagnosis and genetic counseling of SUD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Genetic susceptibility; Indel polymorphism; Ryanodine receptor type-2; Sudden unexplained death; rs10692285

Mesh:

Substances:

Year:  2016        PMID: 27987400     DOI: 10.1016/j.forsciint.2016.12.005

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  Usefulness of Single Nucleotide Polymorphisms as Predictors of Sudden Cardiac Death.

Authors:  Leonardo Tamariz; Javier Balda; Dennise Pareja; Ana Palacio; Robert J Myerburg; Douglas Conway; Lea Davis; Jeffrey J Goldberger
Journal:  Am J Cardiol       Date:  2019-03-20       Impact factor: 2.778

Review 2.  Associations between common ion channel single nucleotide polymorphisms and sudden cardiac death in adults: A MOOSE-compliant meta-analysis.

Authors:  Xiaoli Liu; Jianli Shi; Peilin Xiao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Novel Indel Variation of NPC1 Gene Associates With Risk of Sudden Cardiac Death.

Authors:  Wenfeng Zhao; Qing Zhang; Jiawen Wang; Huan Yu; Xiaoyuan Zhen; Lijuan Li; Yan Qu; Yan He; Jianhua Zhang; Chengtao Li; Suhua Zhang; Bin Luo; Jiang Huang; Yuzhen Gao
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

4.  Re-evaluation of single nucleotide variants and identification of structural variants in a cohort of 45 sudden unexplained death cases.

Authors:  Jacqueline Neubauer; Shouyu Wang; Giancarlo Russo; Cordula Haas
Journal:  Int J Legal Med       Date:  2021-04-25       Impact factor: 2.686

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.